Basata | $21,000,000 | (May 13, 2026)
Corvera (YC W26) | $4,200,000 | (May 13, 2026)
Tolemy Bio
Spain
- Barcelona, Catalonia
- 13/05/2026
- Pre-Seed
- $1,643,411
Nature is building tomorrow’s medicines.
At Tolemy Bio, we are building the AI-native control panel for these cell-derived medicines, combining virtual cell models, big biological data, and wet-lab experimentation to help direct cellular systems toward better therapeutic outcomes.
Our mission is to make cell biology more predictable, programmable, and scalable.
Reach out to info@tolemy.bio learn more
- Industry Biotechnology Research
- Website https://tolemy.bio/
- LinkedIn https://www.linkedin.com/company/tolemy-bio/
Related People
Alex WardCo Founder
Spain -
Barcelona, Catalonia
At Tolemy, we are building the control panel for the cell - an AI-native platform to understand, predict, and direct cellular systems.
My background spans cell & systems biology, bioinformatics, multiomics, and biomanufacturing.
I previously worked at Vow, helping scale exotic animal cell culture toward industrial production; now I’m building Tolemy to make biology more programmable for the next era of medicines manufacturing.
I am lucky every day to be able to build clearer windows into life, and better tools to shape it.
Contact: alex@tolemy.bio
4AM | $4,000,000 | (May 13, 2026)
Ciridae | $20,000,000 | (May 13, 2026)
Sedivention - Freezing the hunger feeling | $3,402,541 | (May 13, 2026)
Meatly | $14,074,996 | (May 13, 2026)
NanoStruct GmbH | $3,050,853 | (May 13, 2026)
Adfin | $18,000,000 | (May 13, 2026)
Boundary | $2,000,000 | (May 13, 2026)
Algorithmiq | $21,122,550 | (May 13, 2026)
Knit Health | $11,600,000 | (May 13, 2026)